New molecular markers for cervical cancer screening: distinguishing hype from hope
Philip E. Castle, PhD, MPH
National Cancer Institute
National Institutes of Health
Dr. Castle received his Ph.D. in Biophysics from the Johns Hopkins University (JHU) in 1995. Dr. Castle then did a post-doctoral fellowship at the NIH on the molecular biology of the zona pellucida. In 1999, he joined the Cancer Prevention Fellowship at NCI and received his MPH from JHU in 2000. He conducted his Cancer Prevention Fellowship training with NCI's Hormonal and Reproductive Epidemiology Branch (2000-2003) and joined the branch as a principal investigator in 2003. His professional interests are (1) epidemiology of human papillomaviruses (HPV) and cervical cancer and other anogenital cancers; and (2) science and translation of cancer prevention strategies.